logo
Select company
Select metric
Ticker Information

Ticker

TLPH

Company Name

TALPHERA INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

TALPHERA INC - Enterprise Value over EBITDA Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TLPH - EV/EBITDA Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)Enterprise ValueEnterprise Value over EBITDA
6/30/2025$ -11.3M$ 8.53M0
3/31/2025$ -11.64M$ 11.6M0
12/31/2024$ -13M$ 6.13M0
9/30/2024$ -15.66M$ 10.57M0
6/30/2024$ -13.66M$ 7.72M0
3/31/2024$ -13.69M$ 11.52M0
12/31/2023$ -17.95M$ 15.83M0
9/30/2023$ -19.94M$ -5.52M0
6/30/2023$ -24.66M$ 7.26M0
3/31/2023$ 50.61M$ -2.19M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TALPHERA INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
  • Over the past 5 years, TALPHERA INC's average EV/EBITDA has been 0.54.
  • The median EV/EBITDA for TALPHERA INC during this period was 0.54
  • TALPHERA INC reached its highest EV/EBITDA over the past 5 years at 0.82.
  • The lowest EV/EBITDA recorded by TALPHERA INC in the same timeframe 0.25

Definition of Enterprise Value over EBITDA

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for TALPHERA INC is calculated as follows: EV [ $ 265.98M ] / EBITDA [ $ -40.72M ]
(=) EV/EBITDA [ 0 ]

TLPH - Enterprise Value over EBITDA, Last 5 years

0.25

Minimum

Sep 30, 2022

0.82

Maximum

Jun 30, 2022

0.54

Average

0.54

Median

EV/EBITDA Benchmark Analysis

The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.49 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
filtered constituents2.44K
min0.01
max40.82
average13.49
median11.75
std7.65